Phthalic anhydride (PA): a valuable substrate in organic transformations

K Nikoofar, M Sadathosainy - RSC advances, 2023 - pubs.rsc.org
This review has been centralized on applications of phthalic anhydride (PA) as a valuable
and significant heterocyclic substrate in two-and multicomponent organic reactions. The …

Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents

MA El-Zahabi, H Sakr, K El-Adl, M Zayed… - Bioorganic …, 2020 - Elsevier
Thalidomide and its analogs are immunomodulatory drugs that inhibit the production of
certain inflammatory mediators associated with cancer. In the present work, a new series of …

Phthalimides as anti-inflammatory agents

HM Heras Martinez, E Barragan… - Future medicinal …, 2025 - Taylor & Francis
ABSTRACT Isoindoline-1, 3-dione, also referred as phthalimide, has gained recognition as
promising pharmacophore due to the documented biological activities of its derivatives …

[HTML][HTML] Synthesis, in vitro and in vivo biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents

L Pang, CY Liu, GH Gong, ZS Quan - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Lappaconitine (LA), a natural compound with a novel C18-diterpenoid alkaloid skeleton,
displayed extensive biological profile. Recent research on LA is focused mainly on its anti …

Discovery of fusidic acid derivatives as novel STING inhibitors for treatment of sepsis

J Long, T Ying, L Zhang, T Yu, J Wu, Y Liu, X Li… - European Journal of …, 2022 - Elsevier
Sepsis is often caused by systemic inflammatory responses. Stimulator of interferon genes
(STING) could be a promising treatment target for sepsis. In this study, we report the design …

Antitumor and immunomodulatory activities of thiosemicarbazones and 1, 3-Thiazoles in Jurkat and HT-29 cells

TAR Dos Santos, AC da Silva, EB Silva… - Biomedicine & …, 2016 - Elsevier
Cancer remains a high incidence and mortality disease, causing around 8.2 million of
deaths in the last year. Current chemotherapy needs to be expanded, making research for …

Privileged structures in the design of potential drug candidates for neglected diseases

ACL Leite, JWP Espíndola… - Current Medicinal …, 2019 - ingentaconnect.com
Background: Privileged motifs are recurring in a wide range of biologically active
compounds that reach different pharmaceutical targets and pathways and could represent a …

Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi

PAT de Moraes Gomes, AR Oliveira… - European journal of …, 2016 - Elsevier
Chagas disease is a parasitic infection caused by protozoan Trypanosoma cruzi that affects
approximately 6–7 million people worldwide. Benznidazole is the only drug approved for …

Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory and analgesic agent

F Gao, Z Dai, T Zhang, Y Gu, D Cai, M Lu, Z Zhang… - RSC …, 2022 - pubs.rsc.org
Sinomenine (SIN) has long been known as an anti-inflammatory drug, while poor efficiency
and large-dose treatment had limited its further application. A series of novel SIN derivatives …

[HTML][HTML] Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives

PM Da Costa, MP da Costa, AA Carvalho… - Chemico-Biological …, 2015 - Elsevier
The strategy of antiangiogenic drugs is based on inhibiting formation of new blood vessels
as alternative to limit cancer progression. In this work, we investigated the antitumor and …